Sernova Biotherapeutics (OTCMKTS:SEOVF) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) shares crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.10 and traded as low as $0.0792. Sernova Biotherapeutics shares last traded at $0.0792, with a volume of 420 shares trading hands.

Sernova Biotherapeutics Trading Down 1.7%

The company has a market capitalization of $29.91 million, a P/E ratio of -1.98 and a beta of 0.84. The company has a 50 day moving average price of $0.10 and a 200 day moving average price of $0.11.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01).

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.